| SF |
STIFEL FINANCIAL CORP |
Fisher Mark P |
|
2026-01-13 |
M - D |
11,335 |
0.00 |
0.00 |
18,779 |
| STUB |
StubHub Holdings, Inc. |
Fitzgerald Scott Michael |
|
2026-01-13 |
F - D |
279 |
13.58 |
3,788.82 |
110,146 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
2,235,468 |
6.71 |
14,999,766.73 |
2,235,468 |
| FHTX |
Foghorn Therapeutics Inc. |
AFEYAN NOUBAR |
|
2026-01-13 |
A - A |
1,117,734 |
0.00 |
0.00 |
1,117,734 |